Delhi Excise Policy and Electoral Bonds: AAP’s BJP Allegation, Aurobindo Pharma Data & 2026 Court Update

The Delhi excise policy case and electoral bonds controversy became intertwined in March 2024 after newly disclosed political-funding data showed that pharmaceutical company Aurobindo Pharma had purchased electoral bonds worth ₹52 crore over several years, with the Bharatiya Janata Party receiving the largest share.

The timing attracted particular attention because P Sarath Chandra Reddy, a director of Aurobindo Pharma who had been arrested in connection with the Delhi excise-policy investigation in November 2022, later became an approver in the Enforcement Directorate’s money-laundering case.

Aam Aadmi Party leaders seized on the electoral-bond disclosures after the arrest of then Delhi Chief Minister Arvind Kejriwal in March 2024. They alleged that the funding raised questions about the BJP’s relationship with Reddy and accused investigative agencies of pursuing AAP while ignoring political donations connected with a person involved in the case.

But several facts need to be separated carefully.

The electoral-bond donations are documented.

AAP’s allegations about what those donations meant were political allegations, not established proof of a quid pro quo.

And the legal case itself changed substantially in 2026 when a Delhi trial court discharged all 23 accused in the CBI corruption case, finding that the prosecution had not established sufficient material to put them on trial. The CBI has appealed that ruling.

Here is the complete, updated picture.

What Was the Delhi Excise Policy Case?

The controversy arose from the Delhi government’s Excise Policy 2021–22, which restructured the way liquor was distributed and sold in the national capital.

Investigative agencies later alleged irregularities in the policy’s formulation and implementation.

The Central Bureau of Investigation alleged that certain private businesses received favourable treatment and that there was a wider conspiracy involving officials, politicians and liquor-industry participants.

The Enforcement Directorate opened a separate money-laundering investigation based on the alleged underlying offences being investigated by the CBI.

AAP consistently rejected the allegations and argued that the investigations were politically motivated.

By 2024, the matter had resulted in a series of high-profile arrests, including former Deputy Chief Minister Manish Sisodia and then Chief Minister Arvind Kejriwal.

The case subsequently became one of India’s most politically significant corruption investigations.

Who Is Sarath Chandra Reddy?

P Sarath Chandra Reddy was associated with Aurobindo Pharma, a major Hyderabad-based pharmaceutical company.

The Enforcement Directorate arrested Reddy on November 10, 2022 in connection with its investigation into the Delhi excise policy.

The ED had alleged that Reddy was connected with the group of businessmen and political figures the agency referred to as the “South Group.”

Those allegations were part of the prosecution’s case and should not be confused with a judicial finding of guilt.

Reddy later received bail on medical grounds and, in June 2023, a Delhi court allowed him to become an approver in the ED case. An approver is an accused person who agrees to provide evidence to the prosecution, usually in exchange for pardon subject to legal conditions.

His statements later became an important part of the political dispute surrounding the investigation.

Why Did AAP Question Sarath Reddy’s Statements?

After Kejriwal’s March 2024 arrest, AAP leader Atishi alleged that Reddy’s statements to investigators had changed.

AAP argued that Reddy initially denied having a relationship with Kejriwal but subsequently provided statements relied upon by investigators after spending time in custody.

AAP alleged that the change occurred under pressure from the Enforcement Directorate.

That last point is important to describe correctly:

AAP alleged that Reddy was pressured. It was not an independently established fact that the ED coerced him into changing his statement.

The original version of this Buzz Content Corner article stated the alleged pressure too definitively.

Contemporary reporting documented AAP’s allegation and the sequence of Reddy’s statements. Read the Economic Times report on AAP’s allegation.

What Did the Electoral Bond Data Actually Show?

This is where the story moved beyond political statements into publicly disclosed financial data.

According to electoral-bond data released following Supreme Court orders, Aurobindo Pharma purchased electoral bonds worth ₹52 crore between April 2021 and November 2023.

The distribution was:

Therefore, the BJP was the largest recipient of Aurobindo Pharma’s electoral-bond donations, but it was not the only political party that received money from the company.

Read the report based on Election Commission electoral-bond data.

That distinction was not clearly explained in the original article.

The ₹5 Crore Donation After Reddy’s Arrest

The timing of one donation became particularly controversial.

Reddy was arrested by the Enforcement Directorate on November 10, 2022.

Five days later, on November 15, 2022, Aurobindo Pharma purchased electoral bonds worth ₹5 crore.

The BJP subsequently encashed those bonds on November 21, 2022.

The timing generated substantial political criticism.

However, timing alone does not prove that the donation was made in exchange for action by an investigative agency or political party.

That is an important distinction for accurate reporting.

What Happened After Reddy Became an Approver?

Reddy became an approver in June 2023.

Later that year, Aurobindo Pharma purchased another ₹25 crore in electoral bonds on November 8, 2023.

According to the disclosed data, the BJP encashed those bonds on November 17, 2023.

An Indian Express analysis noted that Aurobindo Pharma’s electoral bonds purchased before Reddy’s arrest were redeemed by multiple political parties, while the company’s bond purchases identified after his arrest and later developments were redeemed by the BJP.

Read the Indian Express analysis of Aurobindo Pharma’s electoral bonds.

Again, that sequence is a documented fact.

The interpretation that it represented a political quid pro quo was an allegation made by AAP and other opposition figures, not something established merely by the bond data.

What Exactly Did AAP Allege Against the BJP?

AAP leaders argued in March 2024 that the electoral-bond disclosures undermined the prosecution’s narrative against their party.

Atishi and other AAP leaders publicly asked why companies linked to Reddy had financially supported the BJP while Reddy was involved in the excise-policy proceedings.

AAP argued that investigators should examine that political-funding relationship and claimed that the “money trail” raised questions about the BJP rather than AAP.

The party also demanded explanations from the BJP leadership.

Read the Indian Express report on AAP’s allegations.

These were politically significant allegations, but they should be identified as AAP’s claims, rather than reported as proof that the BJP participated in the excise-policy case.

Did the Electoral Bonds Prove BJP Involvement in the Excise Policy Case?

No.

The electoral-bond data proved that Aurobindo Pharma made political donations and that the BJP received the largest portion.

It also established the timing of certain purchases relative to Reddy’s arrest and subsequent role as an approver.

What the data did not by itself prove was that:

the BJP influenced the ED investigation;

the donations were payment for favourable treatment;

Reddy changed his statements because of political pressure; or

the BJP participated in alleged irregularities surrounding Delhi’s excise policy.

Those were matters of political accusation and inference.

This is one of the most important corrections required in the original article.

Why Did Electoral Bond Information Become Public in 2024?

The information became available because of a major Supreme Court decision.

On February 15, 2024, the Supreme Court struck down India’s Electoral Bond Scheme.

The Constitution Bench held that the scheme’s confidentiality provisions violated citizens’ right to information under Article 19(1)(a) and also struck down provisions allowing unlimited corporate political contributions.

The Court directed the State Bank of India to provide electoral-bond purchase and redemption details to the Election Commission of India for disclosure.

You can link readers directly to the:

Supreme Court’s electoral-bonds order

and the

Election Commission’s Electoral Bonds disclosure section.

The disclosure allowed journalists and researchers to match companies purchasing bonds with political parties redeeming them.

That is how the Aurobindo Pharma funding pattern became part of the Delhi excise-policy debate.

Arvind Kejriwal’s 2024 Arrest

The Enforcement Directorate arrested Arvind Kejriwal on March 21, 2024 in connection with its money-laundering investigation.

The agency alleged that Kejriwal and other AAP figures played roles in a wider conspiracy connected with the excise policy.

AAP rejected those accusations and described Kejriwal’s arrest as politically motivated.

The arrest occurred only days after electoral-bond data had become publicly available, intensifying political arguments over both the excise case and corporate political funding.

But what happened after 2024 significantly changed the legal position.

Major 2026 Development: Delhi Court Discharges All 23 Accused in the CBI Case

On February 27, 2026, Special Judge Jitendra Singh of Delhi’s Rouse Avenue Court discharged all 23 accused in the CBI’s excise-policy corruption case, including:

Arvind Kejriwal, Manish Sisodia, K Kavitha, Sarath Chandra Reddy and other individuals accused in the prosecution’s case.

The court concluded that the evidence presented by the CBI did not justify framing charges and found no sufficient material establishing the alleged overarching criminal conspiracy.

The court also criticised aspects of the investigation and the prosecution’s reliance on approver statements.

Read the Indian Express explanation of the February 2026 discharge order.

This is a crucial development missing from the original 2024 article.

Sarath Chandra Reddy Was Also Discharged

The February 2026 order is particularly relevant to this article because Sarath Chandra Reddy was one of the accused who was discharged in the CBI case.

Aurobindo Pharma subsequently informed stock exchanges that the court found insufficient material showing that Reddy participated in the alleged conspiracy, influenced public servants, paid or received illegal gratification, or obtained an unlawful benefit in connection with the Delhi excise policy.

Read Aurobindo Pharma’s February 2026 disclosure.

This later court development makes it inappropriate for a current article to continue describing Reddy simply as if criminal allegations against him had already been proved.

Does “Discharged” Mean “Acquitted”?

Not exactly.

The distinction matters.

A discharge generally means the court determines before trial that the prosecution material is insufficient to proceed with charges.

An acquittal generally follows a trial in which charges were formally framed and evidence was tested.

In this case, the trial court discharged the accused before trial.

That ruling is important, but it can still be challenged by the prosecution — and the CBI has done exactly that.

So the most accurate wording is:

“The accused were discharged by the trial court in the CBI case.”

Avoid saying simply that they were “convicted,” “found guilty,” or even “finally cleared forever,” because the High Court proceedings are still ongoing.

CBI Challenges the 2026 Discharge Order

The CBI moved the Delhi High Court against the February 27 discharge order.

Kejriwal and Sisodia subsequently asked the High Court to dismiss the agency’s revision petition, arguing that it was filed with extraordinary haste and failed to identify specific legal errors in the trial court ruling.

The CBI disputes those arguments and continues to challenge the discharge.

As of the latest available update, on August 17, 2026, the Delhi High Court gave the respondents additional time to file responses and fixed October 5 and October 6, 2026 for the CBI to begin arguments.

Therefore, the CBI case is not completely over.

The trial court discharge currently stands, but it is under challenge.

What About the Enforcement Directorate’s Money-Laundering Case?

The ED’s proceedings are legally connected to the alleged underlying criminal offence.

After the trial court discharged the accused in the CBI case, legal questions immediately arose over whether the ED’s Prevention of Money Laundering Act prosecution could continue if the underlying scheduled offence did not survive.

Legal analysis following the February ruling noted that the CBI discharge was therefore a major setback for the ED case as well, particularly unless the discharge order is stayed or overturned.

However, it would be premature to describe all related litigation as permanently concluded while the CBI’s High Court challenge remains pending.

Delhi Excise Policy and Electoral Bonds: Key Timeline

What Can Be Stated as Fact Today?

Several points are established by public records.

Aurobindo Pharma purchased ₹52 crore worth of electoral bonds.

The BJP received ₹34.5 crore, making it the biggest beneficiary of those Aurobindo Pharma purchases.

Aurobindo also contributed ₹15 crore to BRS and ₹2.5 crore to TDP.

Reddy was arrested in November 2022.

Aurobindo Pharma purchased ₹5 crore of electoral bonds five days later, which the BJP subsequently encashed.

Reddy later became an approver.

AAP subsequently alleged that the sequence demonstrated a problematic connection between the BJP, political donations and the excise-policy investigation.

That allegation was not itself proof of wrongdoing by the BJP.

In February 2026, the trial court discharged all 23 accused in the CBI case.

The CBI’s challenge to that discharge remains before the Delhi High Court.

That balanced distinction is essential for a current, reliable article.

Why This Story Still Matters

The controversy sits at the intersection of three major public-interest issues:

political funding, investigative agencies and criminal allegations involving elected leaders.

The electoral-bond disclosure did not automatically prove corruption.

But it provided information that citizens previously could not easily access: which companies purchased large amounts of political funding and which parties ultimately received those funds.

That transparency allowed voters, journalists and courts to examine political financing relationships much more closely.

The Supreme Court itself identified citizens’ right to information about political funding as central to its decision striking down the electoral-bond scheme.

Frequently Asked Questions

How much did Aurobindo Pharma donate through electoral bonds?

Aurobindo Pharma purchased ₹52 crore worth of electoral bonds between 2021 and 2023.

How much did BJP receive from Aurobindo Pharma?

The BJP received ₹34.5 crore of Aurobindo Pharma’s ₹52 crore in electoral bonds. BRS received ₹15 crore and TDP received ₹2.5 crore.

Did Aurobindo Pharma buy electoral bonds after Sarath Reddy’s arrest?

Yes. Reddy was arrested on November 10, 2022. Aurobindo Pharma purchased ₹5 crore of electoral bonds on November 15, which were subsequently encashed by the BJP on November 21.

Did the electoral bonds prove that BJP was involved in the Delhi excise-policy case?

No. The donations and their timing are documented, but they do not by themselves prove that BJP participated in alleged irregularities or influenced the investigation.

What did AAP allege?

AAP argued that the donations raised questions about the relationship between Reddy, companies associated with him and the BJP. It also alleged that Reddy’s changing statements should be examined in that context.

Was Sarath Chandra Reddy convicted?

No. In February 2026, he was among the 23 accused discharged by the trial court in the CBI corruption case.

Were Arvind Kejriwal and Manish Sisodia discharged?

Yes. The same February 27, 2026 trial court order discharged Kejriwal, Sisodia and the other accused in the CBI case.

Is the Delhi excise-policy case completely finished?

No. The CBI has challenged the discharge order in the Delhi High Court. Arguments on the agency’s challenge are scheduled to begin in October 2026.

Final Takeaway

The relationship between the Delhi excise policy case and electoral bonds became politically explosive because verified funding data appeared alongside an already controversial criminal investigation.

Aurobindo Pharma did purchase ₹52 crore worth of electoral bonds.

The BJP received ₹34.5 crore of that amount, including ₹5 crore in bonds purchased days after Sarath Chandra Reddy’s 2022 arrest.

Those facts legitimately raised questions and became the basis for AAP’s political allegations.

But accurate reporting requires another equally important distinction:

the donation data did not itself establish that the BJP participated in the alleged Delhi excise-policy conspiracy or exchanged investigative favours for political funding.

And the legal picture changed substantially in 2026.

A Delhi trial court discharged Kejriwal, Sisodia, Reddy and the other accused in the CBI case after concluding that the prosecution material did not justify proceeding to trial.

The CBI has challenged that ruling, and the Delhi High Court proceedings continue.

The most responsible conclusion today is therefore neither that the original allegations were conclusively proved nor that all litigation has permanently ended.

The record now consists of documented political donations, competing political claims, a major trial-court discharge order and an ongoing High Court challenge.

For broader background on the investigation, read:

Delhi Excise Policy Case Explained – Buzz Content Corner

For more political coverage:

Buzz Content Corner Politics

You can also read:

Indian General Election 2024: Phases and Key Highlights